HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Amikacin-induced drug reaction with eosinophilia and systemic symptoms syndrome: delayed skin test and ELISPOT assay results allow the identification of the culprit drug.

AuthorsBenoit Bensaid, Aurore Rozieres, Audrey Nosbaum, Jean-François Nicolas, Frédéric Berard
JournalThe Journal of allergy and clinical immunology (J Allergy Clin Immunol) Vol. 130 Issue 6 Pg. 1413-4 (Dec 2012) ISSN: 1097-6825 [Electronic] United States
PMID22840850 (Publication Type: Case Reports, Letter)
Chemical References
  • Anti-Bacterial Agents
  • Interferon-gamma
  • Amikacin
Topics
  • Adult
  • Amikacin (administration & dosage, adverse effects)
  • Anti-Bacterial Agents (administration & dosage, adverse effects)
  • Arthritis, Infectious (drug therapy)
  • Cells, Cultured
  • Drug Hypersensitivity (diagnosis, etiology, immunology)
  • Enzyme-Linked Immunospot Assay
  • Eosinophilia (diagnosis, etiology, immunology)
  • Humans
  • Hypersensitivity, Delayed (diagnosis, etiology, immunology)
  • Interferon-gamma (immunology)
  • Lymphocyte Activation (drug effects)
  • Male
  • Skin Tests
  • Syndrome
  • T-Lymphocytes (drug effects, immunology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: